Lymphatic Malformation Clinical Trial
Official title:
Weekly Sirolimus Therapy for the Treatment of Venous and Lymphatic Malformations
In current practice, options for venous and lymphatic malformations remain limited. Recently an oral medication, sirolimus, has been found to benefit patients when taken once or twice a day for several months. Unfortunately there are many side effects associated with this medication, some of which can be severe including, neutropenia, oral ulcerations, and lab abnormalities. The purpose of this study is to determine if once weekly dosed sirolimus will be effective for the treatment of venous and lymphatic malformations. Additionally, the study will evaluate patient satisfaction and identify adverse effects. Participants will be on the medication for 6 months with an option to continue after this time period.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04409145 -
First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations
|
Phase 1/Phase 2 | |
Completed |
NCT05586919 -
Treatment of Venous Malformation
|
N/A | |
Completed |
NCT04637997 -
Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations
|
N/A | |
Recruiting |
NCT03767660 -
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation
|
Phase 4 | |
Completed |
NCT04486599 -
Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations
|
N/A | |
Completed |
NCT04930952 -
Complications of Ethanol-amine Oleate Intralesional Sclerotherapy
|
||
Recruiting |
NCT05563831 -
National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
|
||
Recruiting |
NCT04258046 -
Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation
|
Phase 2 | |
Active, not recruiting |
NCT01347294 -
Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations
|
Phase 4 | |
Completed |
NCT04836884 -
Vascular Anomaly Pathology and Genomics Biopsy Study
|
N/A | |
Not yet recruiting |
NCT05983159 -
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
|
Phase 2 |